A citation-based method for searching scientific literature

Matthew Ladda, Charles Lynde, Patrick Fleming. J Cutan Med Surg 2020
Times Cited: 4







List of co-cited articles
40 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Evolution of COVID-19 infection in four psoriatic patients treated with biological drugs.
A Conti, C Lasagni, L Bigi, G Pellacani. J Eur Acad Dermatol Venereol 2020
33
75

Lack of Evidence for an Increased Risk of Severe COVID-19 in Psoriasis Patients on Biologics: A Cohort Study from Northeast Italy.
Stefano Piaserico, Paolo Gisondi, Simone Cazzaniga, Luigi Naldi. Am J Clin Dermatol 2020
14
75

SARS-CoV-2 infection in a psoriatic patient treated with IL-17 inhibitor.
R Balestri, G Rech, C R Girardelli. J Eur Acad Dermatol Venereol 2020
25
75


Factors associated with adverse COVID-19 outcomes in patients with psoriasis-insights from a global registry-based study.
Satveer K Mahil, Nick Dand, Kayleigh J Mason, Zenas Z N Yiu, Teresa Tsakok, Freya Meynell, Bola Coker, Helen McAteer, Lucy Moorhead, Teena Mackenzie,[...]. J Allergy Clin Immunol 2021
77
75

COVID-19 in an elderly patient treated with secukinumab.
Vito Di Lernia, Caterina Bombonato, Alberico Motolese. Dermatol Ther 2020
15
75

Improvement of SARS-CoV-2 symptoms following Guselkumab injection in a psoriatic patient.
F Benhadou, V Del Marmol. J Eur Acad Dermatol Venereol 2020
21
75

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry.
Paula Dávila-Seijo, Esteban Dauden, M A Descalzo, Gregorio Carretero, José-Manuel Carrascosa, Francisco Vanaclocha, Francisco-José Gómez-García, Pablo De la Cueva-Dobao, Enrique Herrera-Ceballos, Isabel Belinchón,[...]. J Invest Dermatol 2017
63
75

SARS-CoV-2 infection in a psoriatic patient treated with IL-23 inhibitor.
F Messina, S Piaserico. J Eur Acad Dermatol Venereol 2020
45
75

Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
Ofelia Baniandrés-Rodríguez, Jaime Vilar-Alejo, Raquel Rivera, José Manuel Carrascosa, Esteban Daudén, Enrique Herrera-Acosta, Antonio Sahuquillo-Torralba, Fran J Gómez-García, Lula María Nieto-Benito, Pablo de la Cueva,[...]. J Am Acad Dermatol 2021
18
50


Covid-19 infection in psoriasis patients treated with cyclosporin.
Vito Di Lernia, Mohamad Goldust, Claudio Feliciani. Dermatol Ther 2020
14
50

The impact of the COVID-19 pandemic on patients with chronic plaque psoriasis being treated with biological therapy: the Northern Italy experience.
P Gisondi, P Facheris, P Dapavo, S Piaserico, A Conti, L Naldi, S Cazzaniga, P Malagoli, A Costanzo. Br J Dermatol 2020
81
50

Secukinumab lowers expression of ACE2 in affected skin of patients with psoriasis.
James G Krueger, Dedee F Murrell, Sandra Garcet, Kristina Navrazhina, Patricia C Lee, Elisa Muscianisi, Andrew Blauvelt. J Allergy Clin Immunol 2021
10
50

Psoriasis, COVID-19, and acute respiratory distress syndrome: Focusing on the risk of concomitant biological treatment.
Michela Magnano, Riccardo Balestri, Federico Bardazzi, Carlo Mazzatenta, Carlo R Girardelli, Giulia Rech. Dermatol Ther 2020
11
50

Severe COVID-19 outcomes in patients with psoriasis.
X T Lima, M A Cueva, E M Lopes, M B Alora. J Eur Acad Dermatol Venereol 2020
11
50

Trials of anti-tumour necrosis factor therapy for COVID-19 are urgently needed.
Marc Feldmann, Ravinder N Maini, James N Woody, Stephen T Holgate, Gregory Winter, Matthew Rowland, Duncan Richards, Tracy Hussell. Lancet 2020
348
50


COVID-19: a case for inhibiting IL-17?
Omar Pacha, Mary Alice Sallman, Scott E Evans. Nat Rev Immunol 2020
150
50

Psoriasis and risk of the COVID-19: is there a role for angiotensin converting enzyme (ACE)?
Mohammad Shahidi-Dadras, Mohammadreza Tabary, Reza M Robati, Farnaz Araghi, Sahar Dadkhahfar. J Dermatolog Treat 2022
8
50

Psoriasis pathogenesis and the development of novel targeted immune therapies.
Jason E Hawkes, Tom C Chan, James G Krueger. J Allergy Clin Immunol 2017
374
50

National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.
Joel M Gelfand, April W Armstrong, Stacie Bell, George L Anesi, Andrew Blauvelt, Cassandra Calabrese, Erica D Dommasch, Steven R Feldman, Dafna Gladman, Leon Kircik,[...]. J Am Acad Dermatol 2021
40
50


COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas.
Xianwen Ren, Wen Wen, Xiaoying Fan, Wenhong Hou, Bin Su, Pengfei Cai, Jiesheng Li, Yang Liu, Fei Tang, Fan Zhang,[...]. Cell 2021
162
50

Pustular psoriasis exacerbated by COVID-19 in a patient with the history of psoriasis.
Safoura Shakoei, Alireza Ghanadan, Shahin Hamzelou. Dermatol Ther 2020
12
50


Safety of secukinumab treatment in COVID-19 affected psoriatic patients.
Cristina Mugheddu, Silvia Sanna, Laura Atzori, Franco Rongioletti. Dermatol Ther 2021
6
50

Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China.
Chuan Qin, Luoqi Zhou, Ziwei Hu, Shuoqi Zhang, Sheng Yang, Yu Tao, Cuihong Xie, Ke Ma, Ke Shang, Wei Wang,[...]. Clin Infect Dis 2020
50

Use of systemic therapies for psoriasis in the COVID-19 era.
Donovan G Kearns, Shelley Uppal, Vipawee S Chat, Jashin J Wu. J Dermatolog Treat 2022
5
50

Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study.
Marina Talamonti, Marco Galluzzo, Andrea Chiricozzi, Pietro Quaglino, Gabriella Fabbrocini, Paolo Gisondi, Angelo Valerio Marzano, Concetta Potenza, Andrea Conti, Aurora Parodi,[...]. Expert Opin Biol Ther 2021
28
50

Cytokine profile and disease severity in patients with COVID-19.
Ali Ghazavi, Ali Ganji, Nafiseh Keshavarzian, Somayeh Rabiemajd, Ghasem Mosayebi. Cytokine 2021
60
50


The prevalence of SARS-CoV-2 infection and the severity of the course of COVID-19 in patients with psoriasis treated with biologic therapy.
Piotr Ciechanowicz, Klaudia Dopytalska, Agata Mikucka-Wituszyńska, Monika Dźwigała, Kacper Wiszniewski, Weronika Herniczek, Elżbieta Szymańska, Irena Walecka. J Dermatolog Treat 2022
5
50


Generalized pustular psoriasis following COVID-19.
Mohammad Shahidi Dadras, Reem Diab, Mahsa Ahadi, Fahimeh Abdollahimajd. Dermatol Ther 2021
18
50


Guttate psoriasis secondary to COVID-19.
Kohilan Gananandan, Benjamin Sacks, Iain Ewing. BMJ Case Rep 2020
24
50

Incidence rates of hospitalization and death from COVID-19 in patients with psoriasis receiving biological treatment: A Northern Italy experience.
Paolo Gisondi, Stefano Piaserico, Luigi Naldi, Paolo Dapavo, Andrea Conti, Piergiorgio Malagoli, Angelo Valerio Marzano, Federico Bardazzi, Massimo Gasperini, Simone Cazzaniga,[...]. J Allergy Clin Immunol 2021
25
50

Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.
Daniel Blanco-Melo, Benjamin E Nilsson-Payant, Wen-Chun Liu, Skyler Uhl, Daisy Hoagland, Rasmus Møller, Tristan X Jordan, Kohei Oishi, Maryline Panis, David Sachs,[...]. Cell 2020
50

Should biologics for psoriasis be interrupted in the era of COVID-19?
Mark Lebwohl, Ryan Rivera-Oyola, Dedee F Murrell. J Am Acad Dermatol 2020
115
50


Nonadherence to Treatment and Patient-Reported Outcomes of Psoriasis During the COVID-19 Epidemic: A Web-Based Survey.
Qiaolin Wang, Yan Luo, Chengzhi Lv, Xuanwei Zheng, Wu Zhu, Xiang Chen, Minxue Shen, Yehong Kuang. Patient Prefer Adherence 2020
13
25

Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial.
Kristian Reich, Melinda Gooderham, Diamant Thaçi, Jeffrey J Crowley, Caitriona Ryan, James G Krueger, Tsen-Fang Tsai, Mary Flack, Yihua Gu, David A Williams,[...]. Lancet 2019
109
25

The impact of COVID-19 pandemic in a cohort of Italian psoriatic patients treated with biological therapies.
Federico Pirro, Giacomo Caldarola, Andrea Chiricozzi, Sara Tambone, Marco Mariani, Laura Calabrese, Dario Francesco D'Urso, Clara De Simone, Ketty Peris. J Dermatolog Treat 2022
12
25

Covid-19 in Immune-Mediated Inflammatory Diseases - Case Series from New York.
Rebecca Haberman, Jordan Axelrad, Alan Chen, Rochelle Castillo, Di Yan, Peter Izmirly, Andrea Neimann, Samrachana Adhikari, David Hudesman, Jose U Scher. N Engl J Med 2020
303
25

Coronavirus disease 2019 in a psoriatic patient with concomitant chronic obstructive pulmonary disease under treatment with risankizumab.
Norbert Kiss, Kende Lőrincz, Márta Medvecz, Luca Fésűs, Péter Csuha, Zsolt Hermányi, Norbert Miklós Wikonkál. Dermatol Ther 2020
6
25

Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.
Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino. Dermatol Reports 2020
8
25

Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17?
Andrea Carugno, Daniele Mario Gambini, Francesca Raponi, Pamela Vezzoli, Elisa Robustelli Test, Marco Enrico Giovanni Arosio, Annapaola Callegaro, Paolo Sena. Dermatol Ther 2020
9
25

COVID-19 patients with psoriasis and psoriatic arthritis on biologic immunosuppressant therapy vs apremilast in North Spain.
Rubén Queiro Silva, Susana Armesto, Carmen González Vela, Cristina Naharro Fernández, Miguel Angel González-Gay. Dermatol Ther 2020
23
25



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.